Precision Image Analysis Inc. (PIA), a leading provider of Post-Processing services, is pleased to announce a dramatic expansion of its capabilities as a provider of medical imaging services. Building on its ISO-9001:2008 certification for its Quality Management System, PIA has adopted and implemented comprehensive Core Lab protocols and procedures. This expansion enables PIA to support a wide variety of research activities. Their Core Lab services include design and optimization of protocols, intra-observer and inter-observer analyses, statistical analysis and customized reporting.
In addition, PIA has built a Title 21 CFR Part 11 compliant system that supports the needs of current and future clients who require this level of assurance. Title 21 CFR Part 11 applies to medical device manufacturers, drug makers, biotech companies, biologics developers, CROs and other FDA-regulated industries requiring these companies to implement controls, including audits, system validations, audit trails, electronic signatures and documentation for software systems involved in processing electronic data. "Obtaining this compliance aligns with our company's goal of providing a Gold Standard of Service, which includes providing the highest quality of service with the highest clinical standards available," said Mary Waiss, CEO of Precision Image Analysis.
PIA will be showcasing their Core Lab services along with their remote post-processing solution for cardiac MRI (CMR) and cardiac CT at this year's Radiological Society of North America (RSNA®) annual meeting. RSNA is an international society of radiologists, medical physicists and other medical professionals with more than 54,000 members from 136 countries across the globe.
RSNA 2015 will be held Sunday, November 29 to Friday, December 4, 2015, and located at McCormick Place, 2301 S. Lake Shore Drive, Chicago. PIA will be located at booth #8003, and offering a free case analysis for attendees of RSNA.
Highlights from the meeting include the latest news from more than a dozen scientific press conferences and over 3,100 presentations and posters covering the latest trends in radiologic research on topics such as Alzheimer's disease, stroke, breast cancer, heart disease, and traumatic brain injury.
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation